Skip to content

Clinical trials

Adenocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Clear all

617 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20024
20037
20047
200521
200618
200714
200819
200923
201032
201135
201231
201321
201430
201524
201623
201722
201821
201919
202030
202122
202227
202328
202422
202549
202650

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed273
Recruiting107
Terminated69
Unknown status66
Active, not recruiting34
Not yet recruiting29
Withdrawn26
Enrolling by invitation7
Suspended3
No longer available2
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center13
National Cancer Institute (NCI)13
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins13
Novartis Pharmaceuticals11
H. Lee Moffitt Cancer Center and Research Institute10
UNICANCER10
Astellas Pharma Global Development, Inc.8
Memorial Sloan Kettering Cancer Center8
Stanford University8
University Health Network, Toronto8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma617
Neoplasms122
Prostatic Neoplasms106
Carcinoma, Non-Small-Cell Lung86
Pancreatic Neoplasms83
Stomach Neoplasms72
Carcinoma71
Neoplasm Metastasis66
Carcinoma, Squamous Cell50
Lung Neoplasms50

Trials

Showing 51 to 75 of 617. Each trial links to its page on Pharma Observatory.

517 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.